These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 37678577)

  • 1. Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.
    Chu AWL; Wong MM; Rayner DG; Guyatt GH; Díaz Martinez JP; Ceccacci R; Zhao IX; McMullen E; Srivastava A; Wang J; Wen A; Wang FC; Brignardello-Petersen R; Izcovich A; Oykhman P; Wheeler KE; Wang J; Spergel JM; Singh JA; Silverberg JI; Ong PY; O'Brien M; Martin SA; Lio PA; Lind ML; LeBovidge J; Kim E; Huynh J; Greenhawt M; Gardner DD; Frazier WT; Ellison K; Chen L; Capozza K; De Benedetto A; Boguniewicz M; Smith Begolka W; Asiniwasis RN; Schneider LC; Chu DK
    J Allergy Clin Immunol; 2023 Dec; 152(6):1470-1492. PubMed ID: 37678577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.
    Chu DK; Chu AWL; Rayner DG; Guyatt GH; Yepes-Nuñez JJ; Gomez-Escobar L; Pérez-Herrera LC; Díaz Martinez JP; Brignardello-Petersen R; Sadeghirad B; Wong MM; Ceccacci R; Zhao IX; Basmaji J; MacDonald M; Chu X; Islam N; Gao Y; Izcovich A; Asiniwasis RN; Boguniewicz M; De Benedetto A; Capozza K; Chen L; Ellison K; Frazier WT; Greenhawt M; Huynh J; LeBovidge J; Lio PA; Martin SA; O'Brien M; Ong PY; Silverberg JI; Spergel JM; Smith Begolka W; Wang J; Wheeler KE; Gardner DD; Schneider L
    J Allergy Clin Immunol; 2023 Dec; 152(6):1493-1519. PubMed ID: 37678572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.
    Edwards SJ; Karner C; Jhita T; Barton S; Marceniuk G; Yiu ZZN; Wittmann M
    Health Technol Assess; 2024 Jan; 28(4):1-113. PubMed ID: 38343072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Immunomodulatory Treatments for Atopic Dermatitis: Living Systematic Review and Network Meta-Analysis Update.
    Drucker AM; Lam M; Prieto-Merino D; Malek R; Ellis AG; Yiu ZZN; Rochwerg B; Di Giorgio S; Arents BWM; Mohan T; Burton T; Spuls PI; Schmitt J; Flohr C
    JAMA Dermatol; 2024 Sep; 160(9):936-944. PubMed ID: 39018058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysis.
    Drucker AM; Morra DE; Prieto-Merino D; Ellis AG; Yiu ZZN; Rochwerg B; Di Giorgio S; Arents BWM; Burton T; Spuls PI; Schmitt J; Flohr C
    JAMA Dermatol; 2022 May; 158(5):523-532. PubMed ID: 35293977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic treatments for eczema: a network meta-analysis.
    Sawangjit R; Dilokthornsakul P; Lloyd-Lavery A; Lai NM; Dellavalle R; Chaiyakunapruk N
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013206. PubMed ID: 32927498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms.
    Yepes-Nuñez JJ; Guyatt GH; Gómez-Escobar LG; Pérez-Herrera LC; Chu AWL; Ceccaci R; Acosta-Madiedo AS; Wen A; Moreno-López S; MacDonald M; Barrios M; Chu X; Islam N; Gao Y; Wong MM; Couban R; Garcia E; Chapman E; Oykhman P; Chen L; Winders T; Asiniwasis RN; Boguniewicz M; De Benedetto A; Ellison K; Frazier WT; Greenhawt M; Huynh J; Kim E; LeBovidge J; Lind ML; Lio P; Martin SA; O'Brien M; Ong PY; Silverberg JI; Spergel J; Wang J; Wheeler KE; Schneider L; Chu DK
    J Allergy Clin Immunol; 2023 Jan; 151(1):147-158. PubMed ID: 36191689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis.
    Drucker AM; Ellis AG; Bohdanowicz M; Mashayekhi S; Yiu ZZN; Rochwerg B; Di Giorgio S; Arents BWM; Burton T; Spuls PI; Küster D; Siegels D; Schmitt J; Flohr C
    JAMA Dermatol; 2020 Jun; 156(6):659-667. PubMed ID: 32320001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.
    Davis DMR; Drucker AM; Alikhan A; Bercovitch L; Cohen DE; Darr JM; Eichenfield LF; Frazer-Green L; Paller AS; Schwarzenberger K; Silverberg JI; Singh AM; Wu PA; Sidbury R
    J Am Acad Dermatol; 2024 Feb; 90(2):e43-e56. PubMed ID: 37943240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing binary efficacy outcomes for systemic immunomodulatory treatments for atopic dermatitis in a living systematic review and network meta-analysis.
    Drucker AM; Lam M; Elsawi R; Prieto-Merino D; Malek R; Ellis AG; Yiu ZZN; Rochwerg B; Di Giorgio S; Arents BWM; Burton T; Spuls PI; Schmitt J; Flohr C
    Br J Dermatol; 2024 Jan; 190(2):184-190. PubMed ID: 37831594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and safety of systemic therapies used in moderate-to-severe atopic dermatitis: a systematic literature review and network meta-analysis.
    Silverberg JI; Thyssen JP; Fahrbach K; Mickle K; Cappelleri JC; Romero W; Cameron MC; Myers DE; Clibborn C; DiBonaventura M
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1797-1810. PubMed ID: 33991374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching between JAK Inhibitors in Patients with Atopic Dermatitis: Unanswered Questions in Daily Clinical Practice.
    Mastraftsi S; Bakakis M; Tsiogka A; Afroditi Kleidona I; Gregoriou S
    Acta Dermatovenerol Croat; 2023 Dec; 31(3):162-164. PubMed ID: 38439732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive summary: Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.
    Davis DMR; Drucker AM; Alikhan A; Bercovitch L; Cohen DE; Darr JM; Eichenfield LF; Frazer-Green L; Paller AS; Schwarzenberger K; Silverberg JI; Singh AM; Wu PA; Sidbury R
    J Am Acad Dermatol; 2024 Feb; 90(2):342-345. PubMed ID: 37943241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.
    ; Chu DK; Schneider L; Asiniwasis RN; Boguniewicz M; De Benedetto A; Ellison K; Frazier WT; Greenhawt M; Huynh J; Kim E; LeBovidge J; Lind ML; Lio P; Martin SA; O'Brien M; Ong PY; Silverberg JI; Spergel JM; Wang J; Wheeler KE; Guyatt GH; ; Capozza K; ; Begolka WS; ; Chu AWL; Zhao IX; Chen L; Oykhman P; Bakaa L; ; Golden D; Shaker M; Bernstein JA; Greenhawt M; Horner CC; Lieberman J; Stukus D; Rank MA; Wang J; Ellis A; Abrams E; Ledford D; Chu DK
    Ann Allergy Asthma Immunol; 2024 Mar; 132(3):274-312. PubMed ID: 38108679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term efficacy and safety of biologics and Janus kinase inhibitors for patients with atopic dermatitis: A systematic review and meta-analysis.
    Chen Q; Cui L; Hu Y; Chen Z; Gao Y; Shi Y
    Heliyon; 2023 Nov; 9(11):e22014. PubMed ID: 38034798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate-to-severe atopic dermatitis: A network meta-analysis.
    Wan H; Jia H; Xia T; Zhang D
    Dermatol Ther; 2022 Sep; 35(9):e15636. PubMed ID: 35703351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis.
    Devasenapathy N; Chu A; Wong M; Srivastava A; Ceccacci R; Lin C; MacDonald M; Wen A; Steen J; Levine M; Pyne L; Schneider L; Chu DK;
    Lancet Child Adolesc Health; 2023 Jan; 7(1):13-25. PubMed ID: 36370744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial.
    Simpson EL; Silverberg JI; Thyssen JP; Viguier M; Thaçi D; de Bruin-Weller M; Weidinger S; Chan G; DiBonaventura M; Biswas P; Feeney C; Koulias C; Cork MJ
    Am J Clin Dermatol; 2023 Jul; 24(4):609-621. PubMed ID: 37213005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Old and New Systemic Treatments for Moderate to Severe Atopic Dermatitis.
    Yim HJ; Jean T; Ong PY
    Curr Allergy Asthma Rep; 2024 May; 24(5):289-301. PubMed ID: 38632138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis.
    Sedeh FB; Henning MAS; Jemec GBE; Ibler KS
    Acta Derm Venereol; 2022 Aug; 102():adv00764. PubMed ID: 35818735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.